UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) has earned a consensus rating of “Moderate Buy” from the twenty-two research firms that are currently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, seventeen have assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $628.37.
A number of analysts have recently weighed in on UNH shares. Hsbc Global Res downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Barclays lifted their target price on shares of UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a report on Wednesday, November 27th. Bank of America reduced their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. HSBC cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd.
View Our Latest Report on UnitedHealth Group
Institutional Inflows and Outflows
UnitedHealth Group Price Performance
Shares of UnitedHealth Group stock opened at $513.00 on Wednesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group has a one year low of $436.38 and a one year high of $630.73. The stock has a market capitalization of $472.11 billion, a P/E ratio of 33.42, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62. The business’s 50 day simple moving average is $559.83 and its two-hundred day simple moving average is $561.31.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.56 earnings per share. Analysts forecast that UnitedHealth Group will post 27.61 EPS for the current year.
UnitedHealth Group Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.64%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
- Five stocks we like better than UnitedHealth Group
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- How to Use the MarketBeat Dividend Calculator
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.